Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Salvador F Ausar
A High Ratio of IC31®adjuvant to Antigen Is Necessary for H4 TB Vaccine Immunomodulation
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection Against Tuberculosis
Frontiers in Immunology
Allergy
Immunology
L-Tyrosine Is a Promising Cancer Vaccine Adjuvant
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Influenza Virosomes Supplemented With GPI-0100 Adjuvant: A Potent Vaccine Formulation for Antigen Dose Sparing
Medical Microbiology and Immunology
Medicine
Allergy
Immunology
Microbiology
Degradable Emulsion as Vaccine Adjuvant Reshapes Antigen-Specific Immunity and Thereby Ameliorates Vaccine Efficacy
Scientific Reports
Multidisciplinary
Is Adjuvant Chemotherapy Necessary for Patients With Microinvasive Breast Cancer After Surgery?
Cancer Biology and Medicine
Cancer Research
Oncology
Vaccine Adjuvant Informatics: From Data Integration and Analysis to Rational Vaccine Adjuvant Design
Frontiers in Immunology
Allergy
Immunology
Development of a Virosomal RSV Vaccine Containing 3d-Phad® Adjuvant: Formulation, Composition, and Long-Term Stability
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Vaccination With Antigen Combined With Αβ-Atp as a Vaccine Adjuvant Enhances Antigen-Specific Antibody Production via Dendritic Cell Activation
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
CpG DNA as a Vaccine Adjuvant
Expert Review of Vaccines
Molecular Medicine
Drug Discovery
Immunology
Pharmacology